By Professor Ric Day

Journal articles

JOHNSON AG; NGUYEN TV; DAY RO, 1995, 'NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND HIGH BLOOD-PRESSURE - RESPONSE', ANNALS OF INTERNAL MEDICINE, 122, pp. 397 - 397, http://dx.doi.org/10.7326/0003-4819-122-5-199503010-00028

Conaghan PG; Quinn DI; Brooks PM; Day RO, 1995, 'Hazards of low dose methotrexate', Australian and New Zealand Journal of Medicine, 25, pp. 670 - 673, http://dx.doi.org/10.1111/j.1445-5994.1995.tb02851.x

Johnson AG; Quinn DI; Day RO, 1995, 'Non-steroidal anti-inflammatory drugs', Medical Journal of Australia, 163, pp. 155 - 158, http://dx.doi.org/10.5694/j.1326-5377.1995.tb127972.x

Radack K; Johnson AG; Nguyen TV; Day RO, 1995, 'Nonsteroidal anti-inflammatory drugs and high blood pressure [8]', Annals of Internal Medicine, 122, pp. 397, http://dx.doi.org/10.7326/0003-4819-122-5-199503010-00027

Brooks PM; Day R, 1995, 'Treatment issues', Bailliere S Clinical Rheumatology, 9, pp. 231 - 245, http://dx.doi.org/10.1016/S0950-3579(05)80158-X

Brooks PM; Day RO, 1995, 'Workshop report - Part 1: Toxicity of antirheumatic drugs', Journal of Rheumatology, 22, pp. 998 - 999

Day RO; Quinn DE; Conaghan PG; Tett S, 1995, 'Adverse drug reactions and their measurement in the rheumatic diseases', Journal of Rheumatology, pp. 983 - 988

Quinn DE; Day RO, 1995, 'Clinically Important Drug Interactions.', Drug Safety, 12, pp. 393 - 452

Quinn DE; Day RO, 1995, 'Drug interactions of clinical importance: an updated guide', Drug Safety, 12, pp. 393 - 452

Johnson AG; Quinn DE; Day RO, 1995, 'Non-steroidal anti-inflammatory drugs', Medical Journal of Australia, 163, pp. 155 - 158

Day RO; Francis H; Vial JH; Geisslinger G; Williams KM, 1995, 'Pharmacokinetics and pharmacodynamics of naproxen in synovial fluid and plasma', Journal of Rheumatology, pp. 2295 - 2303

Day RO; Geisslinger G; Paull P; Williams KM, 1995, 'The effect of tenoxicam on tolbutamide pharmacokinetics and glucose concentrations in healthy volunteers', International journal of clinical pharmacology, pp. 308 - 310, https://www.ncbi.nlm.nih.gov/pubmed/7655772

Brooks PM; Day RO, 1995, 'Toxicity of antirheumatic drugs. Toxicity Workgroup Leaders.', J Rheumatol, 22, pp. 998 - 999, https://www.ncbi.nlm.nih.gov/pubmed/8587098

Brooks PM; Day R, 1995, 'Tropical rheumatology. Treatment issues.', Baillieres Clin Rheumatol, 9, pp. 231 - 245, http://dx.doi.org/10.1016/s0950-3579(05)80158-x

Johnson AG; Nguyen TV; Day RO, 1994, 'Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis', Annals of Internal Medicine, 121, pp. 289 - 300, http://dx.doi.org/10.7326/0003-4819-121-4-199408150-00011

Parnham MJ; Day RO; van den Berg WB, 1994, 'Inflammation '93', Agents and Actions, 41, pp. C145 - C149, http://dx.doi.org/10.1007/BF01987616

Johnson AG; Nuygen TV; Day RO, 1994, 'Evaluation of the accuracy and reproducibility of ambulatory blood pressure monitoring in the very elderly using the Takeda TM-2420', Journal of Human Hypertension, 8, pp. 433 - 439

LAU ATS; GRAHAM GG; DAY RO; PERRY MA, 1994, 'EFFECT OF HCL CONCENTRATION ON GASTRIC BLOOD-FLOW IN ACUTE ASPIRIN-INDUCED GASTRIC-ULCERS IN THE CAT', GASTROENTEROLOGY, 106, pp. A123 - A123, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1994NH90900484&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mclachlan AJ; Tett SE; Cutler DJ; Day RO, 1994, 'Bioavailability of hydroxychloroquine tablets in patients with rheumatoid arthritis', Rheumatology, 33, pp. 235 - 239, http://dx.doi.org/10.1093/rheumatology/33.3.235

Day R; Quinn D, 1994, 'Adverse Interaction Between Warfarin and Indomethacin', Drug Safety, 11, pp. 213 - 214, http://dx.doi.org/10.2165/00002018-199411030-00006

Day R; Wodak A; Chesher G, 1994, 'Cannabis and suicide [3]', Medical Journal of Australia, 160, pp. 731, http://dx.doi.org/10.5694/j.1326-5377.1994.tb125924.x

Walker J; Nguyen T; Day R, 1994, 'Clinical response to non‐steroidal anti‐inflammatory drugs in urate‐ crystal induced inflammation: a simultaneous study of intersubject and intrasubject variability.', British Journal of Clinical Pharmacology, 38, pp. 341 - 347, http://dx.doi.org/10.1111/j.1365-2125.1994.tb04364.x

McLachlan AJ; Tett SE; Cutler DJ; Day RO, 1994, 'Disposition and absorption of hydroxychloroquine enantiomers following a single dose of the racemate', Chirality, 6, pp. 360 - 364, http://dx.doi.org/10.1002/chir.530060421

Day R, 1994, 'Meeting report: Asian conference on clinical pharmacology and therapeutics', British Journal of Clinical Pharmacology, 38, pp. 197 - 198

Day R; Geisslinger G; Paull P; Williams K, 1994, 'Neither cimetidine nor probenecid affect the pharmacokinetics of tenoxicam in normal volunteers.', British Journal of Clinical Pharmacology, 37, pp. 79 - 81, http://dx.doi.org/10.1111/j.1365-2125.1994.tb04244.x

Day RO; Birkett DJ; Hicks M; Miners JO; Graham GG; Brooks PM, 1994, 'New Uses for Allopurinol', Drugs, 48, pp. 339 - 344, http://dx.doi.org/10.2165/00003495-199448030-00002

Johnson AG; Seidemann P; Day RO, 1994, 'NSAID-related adverse drug interactions with clinical relevance. An update', International Journal of Clinical Pharmacology and Therapeutics, 32, pp. 509 - 532

Tett SE; McLachlan AJ; Cutler DJ; Day RO, 1994, 'Pharmacokinetics and pharmacodynamics of hydroxychloroquine enantiomers in patients with rheumatoid arthritis receiving multiple doses of racemate', Chirality, 6, pp. 355 - 359, http://dx.doi.org/10.1002/chir.530060420

Conaghan PG; Day RO, 1994, 'Risks and Benefits of Drugs Used in the Management and Prevention of Gout', Drug Safety, 11, pp. 252 - 258, http://dx.doi.org/10.2165/00002018-199411040-00004

Seideman P; Lohrer F; Graham G; Duncan M; Williams K; Day R, 1994, 'The stereoselective disposition of the enantiomers of ibuprofen in blood, blister and synovial fluid.', British Journal of Clinical Pharmacology, 38, pp. 221 - 227, http://dx.doi.org/10.1111/j.1365-2125.1994.tb04345.x

Tett SE; Day RO; Cutler DJ, 1993, 'Concentration-effect relationship of hydroxychloroquine in rheumatoid arthritis - A cross sectional study', Journal of Rheumatology, 20, pp. 1874 - 1879

Day RO; Wacher T; Cairns D; Conners G; Mcgrath M, 1993, 'Nailfold capillary circulation in osteoarthritis', Rheumatology, 32, pp. 1062 - 1065, http://dx.doi.org/10.1093/rheumatology/32.12.1062

McLachlan A; Tett S; Day R; Cutler D, 1993, 'Interpretation of chloroquine pharmacokinetic data', European Journal of Clinical Pharmacology, 44, pp. 407 - 408, http://dx.doi.org/10.1007/BF00316484

Hicks M; Wong LS; Day RO, 1993, 'Suitability of reverse-phase columns from different sources for separation of uric acid from its oxidation products', Analytical Biochemistry, 210, pp. 428 - 430, http://dx.doi.org/10.1006/abio.1993.1221

McLACHLAN AJ; TETT SE; CUTLER DJ; DAY RO, 1993, 'Absorption and in vivo dissolution of hydroxycholoroquine in fed subjects assessed using deconvolution techniques', British Journal of Clinical Pharmacology, 36, pp. 405 - 411, http://dx.doi.org/10.1111/j.1365-2125.1993.tb00388.x

Johnson AG; Seideman P; Day RO, 1993, 'Adverse Drug Interactions with Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Recognition, Management and Avoidance', Drug Safety, 8, pp. 99 - 127, http://dx.doi.org/10.2165/00002018-199308020-00002

Diamond HS; Fitzgerald LL; Day R, 1993, 'An analysis of the cost and revenue of an expanded medical residency', Journal of General Internal Medicine, 8, pp. 614 - 618, http://dx.doi.org/10.1007/BF02599717

WALKER JS; ARROYO JF; NGUYEN T; DAY RO, 1993, 'Analgesic efficacy of non‐steroidal anti‐inflammatory drugs in experimental pain in humans', British Journal of Clinical Pharmacology, 36, pp. 417 - 425, http://dx.doi.org/10.1111/j.1365-2125.1993.tb00390.x

Williams KM; Day RO; Breit SN, 1993, 'Biochemical actions and clinical pharmacology of anti-inflammatory drugs', Advances in Drug Research, 24, pp. 121 - 198

Tett SE; Day RO; Lauchlan R, 1993, 'Clinical pharmacy and clinical pharmacology', Australian Journal of Hospital Pharmacy, 23, pp. 207 - 210

Handel ML; Sivertsen S; Watts CKW; Day RO; Sutherland RL, 1993, 'Comparative effects of gold on the interactions of transcription factors with DNA', Agents and Actions, 44, pp. 219 - 223

McLachlan A; Tett S; Cutler D; Day R, 1993, 'Disposition of the enantiomers of hydroxychloroquine in patients with rheumatoid arthritis following multiple doses of the racemate.', British Journal of Clinical Pharmacology, 36, pp. 78 - 81, http://dx.doi.org/10.1111/j.1365-2125.1993.tb05897.x

Hicks M; Wong LS; Day RO, 1993, 'Identification of products from oxidation of uric acid induced by hydroxyl radicals', Free Radical Research, 18, pp. 337 - 351, http://dx.doi.org/10.3109/10715769309147501

Tett S; McLachlan A; Day R; Cutler D, 1993, 'Insights from pharmacokinetic and pharmacodynamic studies of hydroxychloroquine', Agents and Actions, 44, pp. 145 - 150

Day RO; Brooks PM; Williams KM; Graham GG, 1993, 'Meeting report: Third world conference on variability in response to anti-rheumatic drugs, Singapore, July 22-24, 1992', Agents and Actions, 38

Walker JS; Knihinicki RD; Seideman P; Day RO, 1993, 'Pharmacokinetics of ibuprofen enantiomers in plasma and suction blister fluid in healthy volunteers', Journal of Pharmaceutical Sciences, 82, pp. 787 - 790, http://dx.doi.org/10.1002/jps.2600820806

Brooks PM; Day RO; Graham GG; Williams KM, 1993, 'Preface', Agents and Actions, 44

Kot TV; Day RO; Brooks PM, 1993, 'Preventing acute gout when starting allopurinol therapy. Colchicine or NSAIDs?', Medical Journal of Australia, 159, pp. 182 - 184, http://dx.doi.org/10.5694/j.1326-5377.1993.tb137784.x

Day RO; Brooks PM; Williams KM; Graham GG, 1993, 'Third World conference on variability in response to anti-rheumatic drugs, Singapore, July 22-24, 1992.', Agents and Actions, 38, pp. iv - viii, http://dx.doi.org/10.1007/bf01976204

Day RO, 1993, 'Variability in response to NSAIDs: What progress?', Agents and Actions, 44, pp. 3 - 6

Back to profile page